FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097142 [Registered on: 10/11/2025] Trial Registered Prospectively
Last Modified On: 07/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To study the effect of homoeopathic medicines on dyslipidemia in 20 to 65 years of age 
Scientific Title of Study   A Comparative study on the effectiveness of Moringa oleifera and individualised homoeopathic medicine in the management of Dyslipidemia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Thara Sabu 
Designation  Post Graduate Scholar 
Affiliation  Government Homoeopathic Medical Colllege,Trivandrum 
Address  Department of Organon of Medicine,Government Homoeopathic Medical College, Iranimuttom, Manacaud P. O, Trivandrum

Thiruvananthapuram
KERALA
695009
India 
Phone  8590332440  
Fax    
Email  tharakappalumakkal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Preema E P 
Designation  Professor and head of the department 
Affiliation  Government Homoeopathic Medical College, Trivandrum 
Address  Department of Organon of Medicine, Government Homoeopathic Medical College, Iranimuttom, Manacaud P. O, Trivandrum

Thiruvananthapuram
KERALA
695009
India 
Phone  8547714025  
Fax    
Email  preemariyas@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Thara Sabu 
Designation  Post Graduate Scholar 
Affiliation  Government Homoeopathic Medical Colllege,Trivandrum 
Address  Department of Organon of Medicine, Government Homoeopathic Medical College, Iranimuttom, Manacaud P. O, Trivandrum

Thiruvananthapuram
KERALA
695009
India 
Phone  8590332440  
Fax    
Email  tharakappalumakkal@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Thara Sabu 
Address  Department of Organon of Medicine, Government Homoeopathic medical College,Iranimuttom Manacaud P.O, Thiruvananthapuram, Kerala,India 695009 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Thara Sabu  Government Homoeopathic Medical College, Thiruvananthapuram  Department of Organon of Medicine Government Homoeopathic Medical College,Iranimuttom, Manacaud P.O, Thiruvananthapuram 695009 Kerala, India
Thiruvananthapuram
KERALA 
8590332440

tharakappalumakkal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
GOVERNMENT HOMOEOPATHIC MEDICAL COLLEGE,THIRUVANANTHAPURAM IRANIMUTTOM, MANACAUD P.O THIRUVANANTHAPURAM 695009 INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E789||Disorder of lipoprotein metabolism, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Individualised homoeopathic medicine   Individualised homoeopathic medicine given to second group and reviewed at an interval of 2 to 4 weeks for 3 months 
Intervention  Moringa oleifera  Moringa oleifera of different potencies given to first group and reviewd at an interval of 2 to 4 weeks for 3 months  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Cases satisfying diagnostic criteria where total cholesterol is less than 350 mg/dl.
2. Patients of both sexes
3. Patients in the age group of 20–65 years. 
 
ExclusionCriteria 
Details  1. Cases with other serious illnesses and comorbidities.
2. Cases using lipid lowering drugs and other drugs that affect the lipid metabolism.
3. Cases with total cholesterol more than 350 mg/dl 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
changes in lipid profile values are evaluated especially LDL and HDL levels.  Values are reviewed at an interval of 2 to 4 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   20/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Prospective quasi experimental study will be conducted at Government Homoeopathic Medical College, Thiruvananthapuram over a period of one year. 46 patients aged between 20 and 65 years with total cholesterol below 350 mg per dl will be selected and divided into two groups. One group will be given Moringa oleifera and the other individualised  homoeopathic medicine. The study aims to evaluate and compare the effectiveness of moringa oleifera and individualised homoeopathic medicine in managing dyslipidemia. 
Close